Mutation Screening of Gata4 Gene in CTD Patients Within Chinese Han Population

Yang Liu1, Bojian Li1, Yuejuan Xu1

  • 1Department of Pediatric Cardiology, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.

Pediatric Cardiology
|February 6, 2017
PubMed

Insights

This study investigated GATA4 gene mutations in Chinese Han patients with conotruncal heart defect (CTD). While several variants were identified, the novel A167D mutation did not alter GATA4 protein function, suggesting other CTD mechanisms.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Conotruncal heart defect (CTD) is a severe congenital heart disease with a poor prognosis.
  • Previous studies suggested GATA4 gene missense variants may contribute to CTD, but lacked sufficient evidence due to limited study populations.
  • Understanding the genetic basis of CTD is crucial for improving diagnosis and treatment.

Purpose of the Study:

  • To investigate GATA4 gene mutations in isolated CTD Chinese Han patients.
  • To identify the pathomechanism of identified GATA4 missense mutations.
  • To evaluate the functional impact of a novel GATA4 variant (p.A167D).

Main Methods:

  • Sequencing of GATA4 coding exons and exon-intron boundaries in 600 CTD patients and 300 controls.
  • In silico analysis of the novel GATA4 variant (p.A167D) using PolyPhen 2 and SIFT.
  • Functional assays including luciferase reporter assay and Western blot to assess mutant GATA4 protein activity.

Main Results:

  • Eight heterozygous nonsynonymous GATA4 variants were identified in 22 CTD patients.
  • A novel variant, p.A167D, was identified and predicted to affect protein function by in silico tools.
  • Functional analyses showed no significant alteration in transcriptional activity or protein levels for the A167D mutant GATA4.

Conclusions:

  • The identified GATA4 variants, including the novel A167D mutation, may not be the primary cause of CTD in this cohort.
  • The pathomechanism of CTD in these patients might involve other genetic or environmental factors.
  • Further research is needed to elucidate the complex etiology of conotruncal heart defects.

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593